AC

Alpenglow Capital LP

Long-term holder

Total reported value

—

Reporting period: 2017-03-31 · Number of holdings: 1

Alpenglow Capital LP disclosed 1 holdings in its latest 13F filing for the period ending 2017-03-31, with total reported value of — and a quarterly turnover rate of 0.0%.

Personality snowflake

Concentration
0
Portfolio Stability
0
Momentum/Contrarian
50
Sector conviction
0
Diversification
2
Sizing Uniformity
—

Recent moves

  • Unchanged 000000000

    　$0.0

Holdings Map

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1✓ Ikena Oncology INCStock-Other———

Holding changes this quarter

Position changes disclosed by Alpenglow Capital LP for the quarter ending 2017-03-31, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction
1✓ Ikena Oncology INC——Unchanged

FAQ

What is Alpenglow Capital LP and what type of investor is it?
Alpenglow Capital LP is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2017-03-31), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are Alpenglow Capital LP's largest equity positions?
Based on the latest 13F filing, Alpenglow Capital LP's top holdings by market value are: 1. Ikena Oncology INC — $0.0
What changes did Alpenglow Capital LP make in its most recent portfolio filing?
No notable portfolio changes were recorded for Alpenglow Capital LP in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Alpenglow Capital LP focus on?
Sector breakdown data is not yet available for Alpenglow Capital LP. Check back after the next 13F processing cycle.